Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FUTURA/OASIS 8: UFH Regimens During PCI in ACS Patients Treated with Fondaparinux
NCT00790907Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Allosteric Modulators
- Countries
- 18
01
Overview
A Phase 4 trial of fondaparinux in acute coronary syndrome (ACS), unstable angina, Non-ST-segment elevation myocardial infarction (NSTEMI), sponsored by GSK. Started Feb 2009; status: completed.
02
Drugs
fondaparinux
03
Conditions
acute coronary syndrome (ACS)unstable anginaNon-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00790907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790907.